Spectrum Pharma Cash Flow - Annual (NASDAQ:SPPI)

Add to My Stocks
$21.36 $0.16 (0.74%) SPPI stock closing price Sep 21, 2018 (Closing)

For analyzing any company like Spectrum Pharma from an investment perspective, its important to check the cash flow statement. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Spectrum Pharma profits one has to check the income statement and for Spectrum Pharma debt one has to check the balance sheet. This statement can tell if a company is running out of money while still being profitable and is useful in Spectrum Pharma stock analysis. Spectrum Pharma had a negative net income cash flow of $-91.24M for the latest 2017. This report is very useful in measuring the short term viability of a company. SPPI decrease in investments stood at a value of $-1.08M for the latest year 2017.

View details of Spectrum Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
-91.24M-68.51M-50.78M-45.71M-62.13M94.54M48.51M-48.84M-19.04M-15.46M
Depreciation Depletion Amortization Cash-Flow33.42M32.89M37.78M30.76M9.84M-2.13M-6.65M-7.79M-4.94M-
Net Increase (Decrease) in Assets Liabilities8.13M-17.9M1.33M-15.04M7.67M-0.98M-24.34M25.42M7.21M-2.22M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net10.83M13.05M18.41M26.36M42.53M-19.46M25.76M8.67M-0.86M9.07M
Net Cash from (used by) Operating Activities
-38.85M-40.45M6.74M-3.62M-2.08M71.95M43.28M-22.54M-17.63M-8M
Increase (Decrease) in Prop Plant And Equipment-0.46M-0.07M-0.22M-0.93M-0.16M-0.31M-0.47M-1.57M-0.67M-1.51M
Acquisition Disposition of Subsidiaires-----11.16M-158.69M---30.94M-10.2M
Increase (Decrease) in Investments-0.01M-3.06M4.09M-44.32M1.22M-8.25M25.78M-13.05M
Other Cash Inflow (Outflow) from Investment Activities-0.6M-0.6M--25M-3M-----
Net Cash from (used by) Investment Activities
-1.08M-0.67M2.83M-21.84M-14.33M-114.69M--9.83M-5.83M-24.77M
Issuance (Purchase) of Equity Shares103.23M73.34M1.47M--12.16M-3.97M23.64M3.62M95.94M-
Issuance (Repayment) of Debt Securities-27.5M-8.99M--45M199.99M-0.03M-0.02M--
Increase (Decrease) in Bank & Other Borrowings--4.7M--7M-----
Payment of Dividends & Other Cash Distributions--0.01M----9.01M----
Other Cash from (used by) Financing Activities32.98M----4.57M-0.97M---41.5M
Net Cash from (used by) Financing Activities
108.72M59.64M1.47M-35.25M61.02M23.61M3.59M95.94M41.5M
Effect of Exchange Rate Changes on Cash--0.02M-1.25M-1.7M-2.23M-----
Net Change in Cash & Cash Equivalents
69.1M18.48M9.79M-26.36M16.6M18.49M67.64M-28.77M72.47M8.71M
Cash & Equivalents at Beginning of Year158.22M139.74M129.94M156.3M139.69M121.2M53.55M82.33M9.86M1.14M
Cash & Equivalents at Year End227.32M158.22M139.74M129.94M156.3M139.69M121.2M53.55M82.33M9.86M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Spectrum Pharma stock comparison chart provides an easy way to compare the stock price with peers along with details of Spectrum Pharma stock price history.
The statement of cash flows can be categorized into three main sections:

  • Spectrum Pharma saw a positive change in Net Change in Cash and Cash Equivalents of $69.1M in 2017. Apart from the Spectrum Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-38.85M for SPPI.
  • Cash Flow from investment activities: Spectrum Pharma used $-1.08M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Spectrum Pharma earned $108.72M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Spectrum Pharma Cash Flow